General Information
Revision date
2015-06-08
Product name
2,3 4,5-Di-O-isopropylidene-β-D-fructopyrranose sulfamate
Product Synonyms
Topiramate
Chemical name
2,3 4,5-Di-O-isopropylidene-β-D-fructopyrranose sulfamate
CAS No.
97240-79-4
1.2.1 Relevant identified uses
Monotherapy of epilepsy and adjunctive therapy of Epilepsy
Manufacturer Name
Unichem Laboratories Limited
Icons in SDS
Company Information
company name
Unichem Laboratories Limited
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Emergency Overview Physical State: 25 mg : Light yellow, round, biconvex, film-coated tablets with ‘U’ debossed on one side and ‘115’ debossed on other side 50 mg: White to off-white, round, bevel edged, biconvex, film-coated tablets with ‘U’ debossed on one side and ‘116’ debossed on other side. 100 mg: Salmon, round, bevel edged, biconvex, film-coated tablets with ‘U’ debossed on one side and ‘117’ debossed on other side. 200 mg: Yellow, round, bevel edged, biconvex, film-coated tablets with ‘U’ debossed on one side and ‘118’ debossed on other side. Odor: Not available. WARNING! May be harmful if swallowed. Accidental ingestion of large amounts may be harmful. Primary Route(s) of Entry Ingestion Eyes May Cause eye irritation Skin Slightly hazardous in case of skin contact (irritant) Inhalation Not expected to be an inhalation hazard in final pharmaceutical form. Potential Health Ingestion Ingestion of this material may cause effects such as paresthesia, anorexia, Effects: weight decrease, speech disorder related speech problem, fatigue, dizziness, somnolence, nervousness, psychomotor slowing, abnormal vision and fever. Please see Patient Package Insert for further information Toxicity Data: See Section 11 1 Overdose may cause convulsions, drowsiness, speech disturbance, blurred vision, diplopia, Effects of Overexposure: mentation impaired, lethargy, abnormal coordination, stupor, hypotension, abdominal pain, agitation, dizziness and depression. Target Organs: Central Nervous System